Literature DB >> 17447414

Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.

E Sofic1, A Sapcanin, I Tahirovic, I Gavrankapetanovic, K Jellinger, G P Reynolds, T Tatschner, P Riederer.   

Abstract

Oxidative stress has been associated with damage and progressive cell death that occurs in neurodegenerative disorders such as Parkinson's disease (PD) and Alzheimer's disease (AD). The aim of this study was to investigate the antioxidant capacity in postmortem motor cortex (MC), nucleus caudatus (NC), gyrus temporalis (GT) and substantia nigra (SN) from controls (C) and patients with PD and AD. The initial samples consisted of 68 subjects of PD, AD and C. Brains were matched for age, sex and postmortem time. Brain tissue was homogenized in a phosphate buffer pH 7.3 and separated with two-step centrifugation at 15,000rpm for 30 min and 15,000 rpm for 10 min at 4 degrees C. Antioxidant capacity in the supernatants was measured using the oxygen radical absorbance assay (ORAC). The results showed that in the SN of parkinsonian's brain the balance between production of free radicals and the neutralization by a complex antioxidant system is disturbed. No changes in the antioxidant capacity of postmortem MC and NC of parkinsonian's brain in comparison with C were found. In the SN of parkinsonian's brain, antioxidant capacity seems to be lower in comparison with C (p < 0.05). Antioxidant capacity against peroxyl radical showed that MC of AD patients was lower than in the MC of C (p < 0.005). In NC of AD patients the antioxidant capacity against hydroxyl radical was increased in comparison with C (p < 0.04). No changes in the antioxidant capacity were found in brain tissues of AD in comparison with C, when CuSO4 was used as a free radical generator.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17447414     DOI: 10.1007/978-3-211-33328-0_5

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  16 in total

1.  Antioxidant capacity in the lipophilic fraction of Alzheimer's brain tissues.

Authors:  Aida Sapcanin; Emin Sofić; Ismet Tahirović; Ismet Gavrankapetanović; Kurt Kalcher
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

2.  Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Authors:  E Sofic; M Salkovic-Petrisic; I Tahirovic; A Sapcanin; S Mandel; M Youdim; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-09-25       Impact factor: 3.575

Review 3.  Defective autophagy in Parkinson's disease: role of oxidative stress.

Authors:  Elzbieta Janda; Ciro Isidoro; Cristina Carresi; Vincenzo Mollace
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

4.  Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.

Authors:  Victor S Van Laar; Nikita Roy; Annie Liu; Swati Rajprohat; Beth Arnold; April A Dukes; Cory D Holbein; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2014-12-03       Impact factor: 5.996

5.  DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway.

Authors:  Joo-Young Im; Kang-Woo Lee; Jong-Min Woo; Eunsung Junn; M Maral Mouradian
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

Review 6.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 7.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

8.  Oxidative and nitrosative stress in serum of patients with Parkinson's disease.

Authors:  Hikmet Can Çubukçu; Mustafa Yurtdaş; Zahide Esra Durak; Bilal Aytaç; Hafize Nalan Güneş; Burcu Gökçe Çokal; Tahir Kurtuluş Yoldaş; İlker Durak
Journal:  Neurol Sci       Date:  2016-07-16       Impact factor: 3.307

9.  Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.

Authors:  Ismet Tahirovic; Emin Sofic; Aida Sapcanin; Ismet Gavrankapetanovic; Lidija Bach-Rojecky; Melita Salkovic-Petrisic; Zdravko Lackovic; Siegfried Hoyer; Peter Riederer
Journal:  Neurochem Res       Date:  2007-06-29       Impact factor: 3.996

10.  Parkinson's disease and autophagy.

Authors:  Ana María Sánchez-Pérez; Berta Claramonte-Clausell; Juan Vicente Sánchez-Andrés; María Trinidad Herrero
Journal:  Parkinsons Dis       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.